CONTRAVISORY INVESTMENT MANAGEMENT, INC.

Position in MRK — Merck & Co., Inc.

CIK 1365707 Norwell, MA

Position in MRK

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$9,848,625

+$550,449 QoQ

Shares Held

76,643

-0.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

1.88%

of 13F equity value

Holder Rank

#749

of 3,769 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CONTRAVISORY INVESTMENT MANAGEMENT, INC. holds $32,212,697 across 8 Drug Manufacturers - General names. MRK ranks #1 (30.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc. This page	76,643	$9,848,625
2	BIIB	Biogen Inc.	44,329	$9,577,723
3	PFE	Pfizer Inc	299,290	$7,206,903
4	LLY	ELI LILLY & Co	2,955	$3,544,315
5	JNJ	Johnson & Johnson	4,341	$1,102,483
6	GILD	Gilead Sciences, Inc.	5,737	$724,812
7	ABBV	AbbVie Inc.	777	$195,524
8	AMGN	Amgen Inc	34	$12,312

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,848,625	76,643	-0.8%	Shares	Sole	2026-07-09
2026-03-31	$9,298,176	77,298	+9.0%	Shares	Sole	2026-04-20
2025-12-31	$7,464,302	70,913	+19435.3%	Shares	Sole	2026-01-12
2025-09-30	$30,466	363	-46.9%	Shares	Sole	2025-10-09
2025-06-30	$54,066	683	-36.9%	Shares	Sole	2025-07-10
2025-03-31	$97,210	1,083	-98.5%	Shares	Sole	2025-04-10
2023-12-31	$8,097,678	74,277	-0.9%	Shares	Sole	2024-01-11
2023-09-30	$7,714,455	74,934	-4.0%	Shares	Sole	2023-10-10
2023-06-30	$9,009,651	78,080	+0.7%	Shares	Sole	2023-07-12
2023-03-31	$8,251,395	77,558	-1.4%	Shares	Sole	2023-04-12
2022-12-31	$8,724,220	78,632	+6.1%	Shares	Sole	2023-01-13
2022-09-30	$6,383,300	74,121	-0.4%	Shares	Sole	2022-10-12
2022-06-30	$6,787,424	74,448	+28533.8%	Shares	Sole	2022-07-13
2022-03-31	$21,333	260	-77.0%	Shares	Sole	2022-04-08
2020-03-31	$86,865	1,129	—	Shares	Sole	2020-04-09
No filing history on record for this holder in this stock.